A multi centre randomized open label trial of chloroquine for the treatment of adults with SARS-CoV-2 infection in Vietnam

Background: COVID-19 is a respiratory disease caused by a novel coronavirus (SARS-CoV-2) and causes substantial morbidity and mortality. There is currently no vaccine to prevent COVID-19 or therapeutic agent to treat COVID-19. This clinical trial is designed to evaluate chloroquine as a potential th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Wellcome Open Res
Main Authors: Kestelyn, Evelyne, Dung, Nguyen Thi Phuong, Lam Minh, Yen, Hung, Le Manh, Quan, Nguyen Minh, Dung, Nguyen Thanh, Minh, Ngo Ngoc Quang, Xuan, Tran Chanh, Phong, Nguyen Thanh, Ninh Thi Thanh, Van, Donovan, Joseph, Tu, Tran Nguyen Hoang, Nhat, Le Thanh Hoang, Truong, Nguyen Thanh, Man, Dinh Nguyen Huy, Thao, Huynh Phuong, Ngoc, Nghiêm My, Lam, Vo Thanh, Phat, Huynh Hong, Phuong, Phan Minh, Geskus, Ronald B., Ha, Vo Thi Nhi, Quang, Nguyen Ngo, Tran Tinh, Hien, Tan, Le Van, Thwaites, Guy E., Day, Jeremy N., Chau, Nguyen Van Vinh
Formato: Artigo
Idioma:Inglês
Publicado em: F1000 Research Limited 2020
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7573712/
https://ncbi.nlm.nih.gov/pubmed/33110944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/wellcomeopenres.15936.1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados